Announcement of the status of implementation of the commitments during the up-listing at over-the-counter market

Company’s Board of Directors nominated Michael Chang to serve as the Chairman of the Board
June 27, 2019
Supplementary statement regarding the news article by the Investor and other news media
June 27, 2019
  1. Date of occurrence of the event: Jun 27, 2019
  2. Company name: OBI Pharma Inc.
  3. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office
  4. Reciprocal shareholding ratios: N/A
  5. Cause of occurrence: Announcement of the status of implementation of the commitments during the up-listing at over-the-counter market.
  6. Countermeasures: Company committed to disclose amendment of “Asset Acquisition and Disposal Policy” on MOPS and submit notice to the Taipei Exchange. Status: “Asset Acquisition and Disposal Policy” was approved at the Annual General Meeting on Jun 27, 2019. Relevant information was disclosed in the Meeting Handbook page 59 to 76 as published on MOPS.
  7. Any other matters that need to be specified: Official notice will be submitted to the Taipei Exchange.